Nucleocytoplasmic transport of huntingtin and Huntington's disease

被引:6
|
作者
Truant, R [1 ]
机构
[1] McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada
关键词
nuclear transport; polyglutamine diseases; Huntington's disease; nuclear pore complex; nuclear-mitochondrial communication;
D O I
10.1016/S1566-2772(03)00058-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
One historic characteristic of Huntington's disease (HD), which affected brains in both patient studies and HD mouse models was the detection of elevated levels of huntingtin protein fragments (NNI, neuronal nuclear inclusions) in the nuclei of several neuronal sub-types. This nuclear localization of mutant huntingtin fragments has been implicated as a potential gain of function for polyglutamine expanded huntingtin and may indicate the underlying molecular mechanism of pathology in HID. The nuclear localization of huntingtin fragments also indicates one downstream effect of polyglutamine-induced proteolysis. The mechanism of nuclear entry and the role of proteolysis of huntingtin are not clearly understood and are controversial with respect to the role of polyglutamine. Several groups have now independently detected full-length. intact, normal and mutant huntingtin in the nucleus. Here we discuss recent advances on studies of protein nuclear transport and how proteins enter the nucleus as well as cell biological studies of huntingtin protein. Recent data in publication suggest that wild-type huntingtin may have a normal nuclear role and that the nuclear transport dynamics of huntingtin may be affected during the course of HID. The potential roles of nuclear transport of huntingtin protein for normal biological function, and the consequences of potential nuclear transport defects in HD are discussed. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [1] Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease
    Truant, Ray
    Atwal, Randy Singh
    Burtnik, Anjee
    PROGRESS IN NEUROBIOLOGY, 2007, 83 (04) : 211 - 227
  • [2] Huntington's disease: Huntingtin and the control of axonal transport
    Zala, D.
    Liot, G.
    Humbert, S.
    Saudou, F.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 60 - 60
  • [3] Huntington's Disease: Function and Dysfunction of Huntingtin in Axonal Transport
    Saudou, Frederic
    Humbert, Sandrine
    INTRACELLULAR TRAFFIC AND NEURODEGENERATIVE DISORDERS, 2009, : 115 - +
  • [4] Huntingtin aggregation and toxicity in Huntington's disease
    Bates, G
    LANCET, 2003, 361 (9369): : 1642 - 1644
  • [5] Normal huntingtin function in Huntington's disease
    Cattaneo, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 13 - 13
  • [6] HUNTINGTON'S DISEASE Flipping a switch on huntingtin
    Greiner, Erin R.
    Yang, X. William
    NATURE CHEMICAL BIOLOGY, 2011, 7 (07) : 412 - 415
  • [7] Huntingtin-lowering strategies for Huntington's disease
    Barker, Roger A.
    Fujimaki, Motoki
    Rogers, Priya
    Rubinsztein, David C.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (10) : 1125 - 1132
  • [8] Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease
    Tabrizi, Sarah J.
    Ghosh, Rhia
    Leavitt, Blair R.
    NEURON, 2019, 101 (05) : 801 - 819
  • [9] Targeting Huntingtin in Patients with Huntington's Disease Reply
    Tabrizi, Sarah J.
    Smith, Anne V.
    Bennett, C. Frank
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (12): : 1181 - 1182
  • [10] Role of wild type huntingtin in Huntington's disease
    Cattaneo, E
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76